Visual rating of brain atrophy in structural MRI: Is its time over? - Takeaways - MDSpire

Visual rating of brain atrophy in structural MRI: Is its time over?

  • By

  • Ralph Buchert

  • February 7, 2025

  • 0 min

Share

  • 1

    Structural MRI is crucial for diagnosing cognitive impairment and differentiating primary neurodegenerative diseases.

  • 2

    Visual rating scales for assessing brain atrophy have limitations, including inter-rater variability and low sensitivity.

  • 3

    Automated volumetric assessment tools show promise but lack validation in everyday clinical practice.

  • 4

    The Amygdala Atrophy Scale (ASS) demonstrates strong reliability and potential for improving disease differentiation.

  • 5

    Future research should focus on validating the ASS against clinical data and possibly expanding its rating levels.

Original Source(s)

Visual rating of brain atrophy in structural MRI: Is its time over?

  • by Ralph Buchert

  • February 7, 2025

Related Content

The basics of PET molecular imaging in neurodegenerative disorders with dementia and/or parkinsonism

Outcomes of modern total joint arthroplasty in patients with dementia: a systematic review of challenges and considerations for perioperative care

Mortality and causes of death after surgery for chronic subdural hematoma: a post hoc study of the FINISH randomized trial